Author

V. Marcel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:metagenomics· 1

Frequent Co-Authors

J.-J. Diaz· 2 shared A. Bolon· 1 shared A. Merienne· 1 shared A. Page· 1 shared A. Vincent· 1 shared B. Gillet· 1 shared B. Panthu· 1 shared C. Dubois· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J.-J. Diaz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting a shared neoepitope derived from non-canonical translation of c-MYC oncogene in cancer cells

S. Depil, E. Baulu, A. Bolon, E. Etchegaray, F. Raimundo, A. Merienne, J. Martin, J. Grandsire, T. Richard, L. Tonon, C. Dubois, Y. Estornes, R. Boulos, O. Tabone, P. Bonaventura, , J.-J. Diaz

The paper identifies a shared neoepitope from non-canonical c-MYC translation in cancer cells that activates T cells to kill tumors without harming normal cells.

bioRxiv · May 23, 2024 · PreprintImmunology

SURF2 is a MDM2 antagonist in triggering the nucleolar stress response

S. Tagneres, P. Espirito-Santo, J. Radermecker, D. Rinaldi, C. Froment, Q. Provost, S. Capeille, N. J. Watkins, J. Marcoux, P.-E. Gleizes, V. Marcel, C. Plisson-Chastang, S. LEBARON

The paper identifies SURF2 as a MDM2 antagonist that modulates nucleolar stress responses by buffering free-5S RNP particles, linking it to cancer resistance and patient survival.

bioRxiv · Jan 9, 2024Cell Biology

Alteration of ribosome function upon 5-fluorouracil treatment favours cancer cell drug-tolerance

G. Therizols, Z. Bash-Imam, B. Panthu, C. Machon, A. Vincent, S. Nait Slimane, M. Garcia, F. Laforets, V. Marcel, J. Boubaker-Vitre, G. Souahlia, M.-A. Albaret, H. C. Mertani, M. Prudhomme, M. Bertrand, , J.-J. Diaz

This study shows that 5-FU treatment creates fluorinated ribosomes that selectively translate survival genes, promoting drug tolerance in cancer cells.

bioRxiv · Jun 4, 2020 · PreprintCancer Biology